title: The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
authors.affiliation: Dept of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
authors.forename: H E
authors.initials: HE
authors.lastname: Wilczek
authors.forename: E
authors.initials: E
authors.lastname: Berglin
authors.forename: I
authors.initials: I
authors.lastname: Blohmé
authors.forename: L
authors.initials: L
authors.lastname: Bäckman
authors.forename: I
authors.initials: I
authors.lastname: Fehrman
authors.forename: R
authors.initials: R
authors.lastname: Källen
authors.forename: G
authors.initials: G
authors.lastname: Nyberg
authors.forename: J
authors.initials: J
authors.lastname: Säwe
authors.forename: J
authors.initials: J
authors.lastname: Wahlberg
mesh_terms: D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D016027:Heart Transplantation / Q000276:immunology; D016041:Heart-Lung Transplantation / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D016035:Pancreas Transplantation / Q000276:immunology; D013548:Sweden
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine